Filing Details
- Accession Number:
- 0001181431-13-016744
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-13 18:13:11
- Reporting Period:
- 2013-03-11
- Filing Date:
- 2013-03-13
- Accepted Time:
- 2013-03-13 18:13:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1484478 | Furiex Pharmaceuticals Inc. | FURX | Pharmaceutical Preparations (2834) | 271197863 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106813 | P Robert Ruscher | C/O Furiex Pharmaceuticals, Inc. 3900 Paramount Parkway, Suite 150 Morrisville NC 27560 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-03-11 | 8,825 | $13.45 | 8,825 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-03-11 | 8,675 | $13.94 | 17,500 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-03-11 | 17,570 | $9.11 | 35,070 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-11 | 23,565 | $41.74 | 11,505 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-12 | 4,262 | $40.71 | 7,243 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (to buy) | Disposition | 2013-03-11 | 8,825 | $0.00 | 8,825 | $13.45 |
| Common Stock | Stock Options (to buy) | Disposition | 2013-03-11 | 8,675 | $0.00 | 8,675 | $13.94 |
| Common Stock | Stock Options (to buy) | Disposition | 2013-03-11 | 17,570 | $0.00 | 17,570 | $9.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-10-12 | No | 4 | M | Direct | |
| 0 | 2021-05-19 | No | 4 | M | Direct | |
| 0 | 2020-06-17 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (to buy) | $18.22 | 2022-05-24 | 17,500 | 17,500 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2022-05-24 | 17,500 | 17,500 | Direct |
Footnotes
- The options were awarded on 10/12/2011 and vest and become exercisable in full on the earlier of 5/19/2012 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- The options were awarded on 5/19/2011 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- The options were awarded on 6/17/2010 and vest and become exercisable in full on the earlier of the first anniversary of the date of grant or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
- The options were awarded on 5/24/2012 and vest and become exercisable in full on the earlier of 5/24/2013 or immediately prior to the next election of directors of the Company, provided that the Optionee is still at that time serving on the Company's Board of Directors.
Billionaire Hedge Funds
